Replies to post #11445 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

BAX’s pharma spin-off (MNTA’s FoB partner) may relocate to Boston (which would facilitate working with MNTA):

http://www.fiercebiotech.com/story/report-big-split-baxter-looks-relocate-biopharma-boston/2014-08-28

For months now rumors of a big prospective biotech relocation have been circulating in the hot Boston hub. And now the Boston Business Journal, a weekly with its ear to the ground on all things related to real estate, reports that its sources are saying that the company in question is Baxter International.

Currently based in Deerfield, IL, Baxter is splitting itself in two, spinning out its biopharma work into a separate company. The BBJ reports that its real estate sources have been looking for 150,000 to 200,000 square feet of space to accomodate Baxter, with another 200,000 square feet of lab space in the second phase of development.